AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

TEM · NASDAQ · Medical - Healthcare Information Services

Tempus AI (TEM)

Links clinical testing, multimodal data, and AI applications across precision medicine.

$77.02

vs last close−1.01 (−1.29%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	136	148	146	166	181	201	256	315	334	367	348	382
Cost of revenue	62	66	68	90	75	79	101	120	124	129	126	136
Gross profit	74	82	78	76	106	122	155	195	210	238	222	246
	119	134	131	609	159	173	224	257	271	299	307	322
Research & development	47	49	51	146	58	61	69	76	83	91	94	97
Selling, general & administrative	71	85	80	463	101	111	155	181	188	192	213	226
Other expenses	0	0	0	0	0	0	0	0	0	16	0	0
Operating income	−45	−52	−53	−533	−54	−51	−69	−62	−61	−61	−85	−76
	−9	2	−11	−19	−22	38	−46	19	−19	1	−41	82
Interest income	1	2	1	2	5	4	2	1	5	5	4	4
Interest expense	12	14	13	13	14	13	18	22	15	15	14	10
Other non-operating income	−4	−16	−2	5	7	−54	26	−43	5	−20	24	−95
Income before tax	−53	−50	−65	−552	−76	−13	−114	−43	−80	−60	−126	6
Income tax expense	0	0	0	0	0	0	−46	0	0	−6	0	0
Net income from continuing operations	−53	−50	−65	−552	−76	−13	−68	−43	−80	−54	−126	6
Net income	−53	−50	−65	−552	−76	−13	−68	−43	−80	−54	−126	6
EPS, basic	−$0.38	−$0.44	−$0.55	−$3.66	−$0.46	−$0.08	−$0.40	−$0.25	−$0.46	−$0.30	−$0.70	$0.03
EPS, diluted	−$0.38	−$0.44	−$0.55	−$3.66	−$0.46	−$0.08	−$0.40	−$0.25	−$0.46	−$0.30	−$0.71	$0.03
Weighted average shares, basic	170	154	170	154	166	162	171	173	175	174	179	180
Weighted average shares, diluted	170	154	170	154	166	162	171	173	175	174	179	182
EBITDA	−33	−28	−42	−530	−51	12	−74	9	−39	−15	−82	45
Depreciation & amortization	8	9	9	9	9	9	20	28	27	27	26	26
EBIT	−41	−37	−51	−539	−60	3	−94	−19	−66	−42	−109	19